Filing Flows

Filing Flows › Journey Medical (DERM) › Who owns the stock

Who owns Journey Medical (DERM) stock

67 funds reported Journey Medical (DERM) shares in their latest 13F filings, worth $78.1M in all. The largest holder is Wasatch Advisors LP ($16.8M). Last quarter 39 funds added to their stakes and 42 cut them.

Largest holders of DERM (13F)Largest holders of DERM (13F)Wasatch Advisors LP$16.8MTang Capital Management LLC$11.4MVanguard Group$5.9MVanguard Capital Management LLC$4.8MPunch & Associates Investment Man…$3.8MPale Fire Capital SE$3.7MOpaleye Management$2.5MSummit Financial, LLC$2.5MJane Street Group, LLC$2.3MDiametric Capital, LP$2.1M

Largest holders (13F)

FundSharesValueChangeQuarter
Wasatch Advisors LP2,449,253$16.8Mdecrease2026-09-30
Tang Capital Management LLC1,610,000$11.4Munchanged2026-06-30
Vanguard Group764,147$5.9Mincrease2025-12-31
Vanguard Capital Management LLC675,185$4.8Mdecrease2026-06-30
Punch & Associates Investment Management536,000$3.8Mnew2026-06-30
Pale Fire Capital SE528,584$3.7Mincrease2026-06-30
Opaleye Management350,000$2.5Mdecrease2026-06-30
Summit Financial, LLC346,748$2.5Mdecrease2026-06-30
Jane Street Group, LLC320,021$2.3Mnew2026-06-30
Diametric Capital, LP295,663$2.1Mincrease2026-06-30
Ikarian Capital, LLC251,436$1.8Munchanged2026-06-30
Renaissance Technologies LLC229,700$1.6Mdecrease2026-06-30
Geode Capital Management, LLC216,004$1.5Mdecrease2026-06-30
American Financial Group180,000$1.3Munchanged2026-06-30
Trexquant Investment LP171,338$1.2Mincrease2026-06-30

Journey Medical's latest quarter

Journey Medical, Q2 2026: revenue $18.5M (+23% year over year), operating margin 2.5%, net loss $312K, operating cash flow −$1.7M. The chart follows the revenue to costs, profit and cash.

Questions

Who owns the most DERM stock?

By the latest 13F filings: Wasatch Advisors LP ($16.8M); Tang Capital Management LLC ($11.4M); Vanguard Group ($5.9M); Vanguard Capital Management LLC ($4.8M); Punch & Associates Investment Management ($3.8M).

What is the short interest in DERM?

2,987,988 shares were sold short at the 2026-10-15 settlement, -2.22% of the float.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.